About Boule

Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.

The business was founded in 1992 with the acquisition of Karo Bio Diagnostics AB. But the company’s history goes back to the 1950′s when the founder of Swelab Instrument AB, Erik Öhlin, developed Europe’s first automatic blood cell counter. This is an early predecessor of today’s instruments from Boule. The founders of Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., (CDS) has a similar history from Coulter Corporation which developed the world’s first blood cell counter.

Presentations

Company presentation Q3 2018

Download pdf »


Company presentation Q2 2018

Download pdf »


Company presentation Q1 2018

Download pdf »


Boule Company presentation March 21, 2018

Download pdf »


Company presentation, Q4 and year-end report 2017

Download pdf »


Company presentation and Q3 report September 8, 2017

Download pdf »


Company presentation and Q2 report August 25, 2017

Download pdf »


Boule Diagnostics AB company presentation 2017-08-17

Download pdf »


Presentation vid Boule Diagnostics AB årsstämma 2017

Download (Swedish) pdf »


Presentation vid Boule Diagnostics AB årsstämma 2016

Download (Swedish) pdf »


Boule Diagnostics AB bolagspresentation – Aktiespararnas Aktiedagen 2015-03-09

Download (Swedish) pdf »


Boule Diagnostics AB företagspresentation – LifeScience/Healthcare-dagen 2014-03-05

Download (Swedish) pdf »


Boule Diagnostics AB bolagspresentation 2013-04-23

Download (Swedish) pdf »